Frequently Asked Questions

Key answers regarding Zohra Health Group's phased healthcare model, Stage A services, 38 planned departments, US & Canadian regulatory compliance, and partnership opportunities.

01 Business Model (Section 4)

Why does Zohra Health Group begin with an Outpatient Medical Centre (Stage A) before building a full hospital?

In both the United States and Canada, acute-care hospitals require substantial capital expenditure, complex multi-year facility licensing, accreditation, and large clinical workforces. Launching with a Stage A Outpatient Medical Centre allows Zohra Health Group to begin operations with manageable capital, establish immediate community trust and referral networks, generate early operational cash flow, and expand into Stages B, C, D (Hospital), and E based on verified demand.

02 Initial Scope (Section 9)

Which services are offered in the initial Stage A Medical Centre?

Section 9 specifies 9 recommended initial services: (1) Family Medicine, (2) Internal Medicine, (3) Selected Specialist Consultations (visiting or part-time), (4) Physiotherapy, (5) Dermatology, (6) Diabetes & Endocrinology Consultations, (7) Dietary & Nutrition Services, (8) Basic Diagnostic Coordination (sample collection, ECG, point-of-care testing, and accredited lab/imaging referrals), and (9) Administration & Patient Services.

03 Long-Term Plan (Section 10)

How are the 38 planned departments organized across the expansion stages?

Section 10 categorizes all 38 specialties by their target activation stage: Initial Stage specialties (Family Medicine, Internal Medicine, Physiotherapy, Dermatology, Diabetes & Endocrinology, Dietary Clinic), Diagnostic Core (Laboratory, Radiology & Imaging, Chemical Pathology), Specialist Expansion (Cardiology, Neurology, Orthopaedics, Paediatrics, OB/GYN, ENT, Ophthalmology, Psychiatry, Pulmonology, Rheumatology, Urology, etc.), and Hospital/Surgical Stage (Emergency Department/ER, ICU/Critical Care, Anaesthesia, General Surgery, Neurosurgery, Vascular Surgery, Neonatology, Oncology).

04 Governance (Sections 6 & 7)

How is Zohra Health Group governed and what is the verification policy for leadership?

Zohra Health Group is led by Founder Dr. Sarah, governed by the Board of Directors (Dr. Danish Mushtaq, Sakandar Hayat, and Dr. Laraib Usman), and supported by Health Director Dr. Awias Ur Rehman, Project Lead Neil Robert, and Team Management (HR, HR Executive, and clinical/corporate operations), alongside 5 specialized Board Committees (Finance, Audit & Risk; Clinical Quality & Patient Safety; Governance, Ethics & Compliance; HR & Remuneration; Strategy, Investment & Development). Per Section 6, verified biographies, academic credentials, professional licenses, and written consents are formally attached prior to regulatory submission or investor due diligence.

05 Investment & Partnerships (Sections 14, 15 & 19)

What types of strategic partners and investors can collaborate with Zohra Health Group?

Section 19 invites collaboration across 8 partner categories: (1) Equity Investors, (2) Healthcare Operators, (3) Physicians & Specialist Groups, (4) Diagnostic Laboratory & Imaging Providers, (5) Medical Equipment Suppliers, (6) Healthcare Technology/EMR Providers, (7) Property & Real Estate Development Partners, and (8) Financial, Legal & Regulatory Advisors.

06 Facility & Privacy (Sections 11, 12 & 13)

How are facility design and patient data privacy managed in the USA and Canada?

The initial facility is organized into 8 functional clinical and administrative zones meeting infection control, ADA/accessibility, fire safety, and HVAC standards (Section 11). Digital operations run on 9 integrated systems (Section 12) engineered for full compliance with HIPAA in the United States and PIPEDA plus provincial health information privacy laws in Canada (Section 13).